Homoharringtonine, an approved anti-leukemia drug, suppresses triple negative breast cancer growth through a rapid reduction of anti-apoptotic protein abundance.
| Image |  |
|---|---|
| Description | scientific article published in May 2019 |
| Author/s |
author: Arnaud Briat |
| Publication date | May 1, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |